Omega Therapeutics Other Current Liabilities

Omega Therapeutics (OMGA) currently reports a other current liabilities of $6.8M as of September 2024. That compares with $300K in the prior-year period — up 2173.3% year over year. Use the charts on this page to explore Omega Therapeutics's other current liabilities history and peer comparisons.

Omega Therapeutics's other current liabilities increased from $300K to $6.8M — a 2173.3% year-over-year increase (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Omega Therapeutics reported $6.8M in other current liabilities as of September 2024. That compares with $300K in the prior-year period — up 2173.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $6.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Omega Therapeutics, and consider following OMGA for alerts when major investors trade the stock.

Omega Therapeutics is classified in the Healthcare sector. On other current liabilities, it currently shows $6.8M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OMGA with unrelated industries.